Recommended Reading

DAY 1

• Tracking universal health coverage: first global monitoring report
• Tracking universal health coverage: 2017 global monitoring report
• Primary health care on the road to universal health coverage: 2019 monitoring report

DAY 2
Bibliography of Session "Public Health Functions: Ensuring the Safety of Medicines"

• “A Perspective on the AstraZeneca COVID-19 Vaccine Uncertainty,” March 16, 2021. Accessed at: http://www.pvmarquez.com/vacunacovid-19dilema
   
• “Monitoring the Safety & Effectiveness of COVID-19 Vaccines and Vaccination,” June 9, 2021.  Accessed at: https://blogs.worldbank.org/health/monitoring-safety-effectiveness-covid-19-vaccines-and-vaccination
   
• “Learning from Korea’s experience monitoring drug and vaccine safety,” December 17, 2021.  Accessed at: https://blogs.worldbank.org/health/learning-koreas-experience-monitoring-drug-and-vaccine-safety
   
• “The value of a regional harmonized approach in monitoring the safety of vaccines and other medicines,” February 8, 2022.  Accessed at: https://blogs.worldbank.org/health/value-regional-harmonized-approach-monitoring-safety-vaccines-and-other-medicines
   
• The urgency of establishing the African Medicines Agency,” September 20, 2021. Accessed at: https://blogs.worldbank.org/health/urgency-establishing-african-medicines-agency
   
• Trifirò, Gianluca, and Salvatore Crisafulli. 2022. “A New Era of Pharmacovigilance: Future Challenges and Opportunities.” Frontiers in Drug Safety and Regulation 2 (February 25). https://www.frontiersin.org/articles/10.3389/fdsfr.2022.866898/full.
   
• WHO (World Health Organization). 2015. “WHO Pharmacovigilance Indicators: A Practical Manual for the Assessment of Pharmacovigilance Systems.” WHO, Geneva. https://apps.who.int/iris/handle/10665/186642
   
• Montané, Eva, and Javier Santesmases. 2020. “Adverse Drug Reactions.” Medicina Clínica 154 (5): 178–84. https://pubmed.ncbi.nlm.nih.gov/31771857/ 
   
• Pediaa. 2015. “Difference between Side Effect and Adverse Effect.” Medical Terms (blog), October 21, 2015. https://pediaa.com/difference-between-side-effect-and-adverse-effect/ 
   
• Marquez, Patricio V., and Albert Figueras. 2021a. “The Deadly Risk of Hospital-Acquired Infections and Antimicrobial Resistance for COVID-19 Patients.” (blog), February 13, 2021. http://www.pvmarquez.com/amrcovid19 
   
• Habarugira, Jean Marie Vianney, Linda Härmark, and Albert Figueras. 2021. “Pharmacovigilance Data as a Trigger to Identify Antimicrobial Resistance and Inappropriate Use of Antibiotics: A Study Using Reports from the Netherlands Pharmacovigilance Centre.” Antibiotics 10 (12), 1512. https://www.mdpi.com/2079-6382/10/12/1512/htm 
   
• Marquez, Patricio V., Sarah Eyman, and Betty Hanan. 2021. “To Vaccinate or Not to Vaccinate? The COVID-19 Vaccination Dilemma.” (blog), June 22, 2021.
  http://www.pvmarquez.com/vaccinehesitancy 

DAY 3

• Vital Signs Profiles: https://improvingphc.org/vital-signs-profiles
• Bangladesh PHCPI report: The Primary Health Care System of Bangladesh: A Primary Health Care Performance Initiative Assessment
• Colombia PHC report: Primary Health Care Vital Signs Profile Assessment for Colombia
• Colombia PHC system video
• Costa Rica report: Analysis of Primary Health Care System Capacity in the Huetar Atlantica Region of Costa Rica
• Health case (2019) 
• eHealth case (2019) 
• WHO continuity survey (2020) 
• WHO continuity survey (2021)
• WHO continuity survey (2022)
• Global Burden of Disease: https://www.healthdata.org/gbd/2019

DAY 4

• Risking Your Health: Causes, Consequences, and Interventions to Prevent Risky Behaviors (2014)
• WDR 2015: Mind, Society and Behavior